In this study, the anticancer effects of five different food supplements were investigated on osteosarcoma Saos-2 cancer cell line.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Objective: Nowadays medicinal plants have been considered as complementary medicine in cancer treatment by many researchers.
📊
Key Findings & Data:Osteosarcoma, one of the most common malignant tumors, which is more common at a young age; It is one of the most common types of cancer that occur in mesenchymal bone-forming cells and affect the musculoskeletal system.
💡
Conclusion & Impact:In this study, the anticancer effects of five different food supplements were investigated on osteosarcoma Saos-2 cancer cell line.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Osteosarcoma · Anticancer · Saos-2
Abstract
Objective: Nowadays medicinal plants have been considered as complementary medicine in cancer treatment by many researchers. Osteosarcoma, one of the most common malignant tumors, which is more common at a young age; It is one of the most common types of cancer that occur in mesenchymal bone-forming cells and affect the musculoskeletal system. Today instead of cancer drugs due to their numerous side effects that can suppress or prevent cancer treatment, food supplement products that contain plant extracts may be preferred. In this study, the anticancer effects of five different food supplements were investigated on osteosarcoma Saos-2 cancer cell line.
AĞAN, K., ZARRİNGHALAMİ, R., AĞAN, A. F., YAŞAR, M. (2020). Anticancer Effect of Food Supplements on Saos-2 Osteosarcoma Cell. International Journal of Traditional and Complementary Medicine Research, Cilt: 1 - Sayı: 1, 18–24. https://ajindex.com/articles/769540
Li T, Jiang S, Yang Y. Database selection and heterogeneity?more details, more credibility. JAMA Oncol. 2018
4(9):1295. doi:10.1001/jamaoncol.2018.1209 2. Picci P, Mercuri M, Ferrari S, et al. Survival in high-grade osteosarcoma: Improvement over 21 years at a single institution. Ann Oncol. 2009
21(6):1366-1373. doi:10.1093/annonc/mdp502 3. Mertens WC, Bramwell V. Osteosarcoma and other tumors of bone. Curr Opin Oncol. 1994
6(4):384-390. doi:10.1097/00001622-199407000-00010 4. Mirabello L, Troisi RJ, Savage SA. Osteosarcoma incidence and survival rates from 1973 to 2004. Cancer. 2009
115(7):1531-1543. doi:10.1002/cncr.24121 5. Winslow LC, David K j. Herbs as Medicines. 2015
Ma XH, Zheng CJ, Han LY, et al. Synergistic therapeutic actions of herbal ingredients and their mechanisms from molecular interaction and network perspectives. Drug Discov Today. 2009
14(11-12):579-588. doi:10.1016/j.drudis.2009.03.012 7. Xiangyong Y, Zhongsheng Y, Wenchao L, et al. External application of traditional Chinese medicine in the treatment of bone cancer pain: a meta-analysis. Support Care Cancer. 2016
24(1):11-17. doi:10.1007/s00520-015-2737-2 8. Atalay D, Erge HS. Dietary Supplements and Their Effects on Health. Food Heal. 2018
4(2):98-111. doi:10.3153/fh18010 9. Lange D. Europe’s medicinal and aromatic plants: their use, trade and conservation. Eur Med Aromat plants their use, trade Conserv. 1998. https://www.cabdirect.org/cabdirect/abstract/19980314129. Accessed October 2, 2018. 10. Manel M, Nouzha H, Rim M, et al. Antibacterial and antioxidant activity of Juniperus thurifera L. leaf extracts growing in East of Algeria. Vet World. 2018
11(3):373-378. doi:10.14202/vetworld.2018.373-378 11. Kusari S, Lamshöft M, Spiteller M. Aspergillus fumigatus Fresenius, an endophytic fungus from Juniperus communis L. Horstmann as a novel source of the anticancer pro-drug deoxypodophyllotoxin. J Appl Microbiol. 2009
107(3):1019-1030. doi:10.1111/j.1365-2672.2009.04285.x 12. Fernandez A, Journal IC-P, 2016 undefined. The Therapeutic Properties of Juniperus communis L.: Antioxidant Capacity, Bacterial growth Inhibition, Anticancer Activity and Toxicity. PhcogjCom. https://sci-hub.tw/http://phcogj.com/article/148. 13. Lim GP, Chu T, Yang F, Beech W, Frautschy S a, Cole GM. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci. 2001
21(21):8370-8377. doi:21/21/8370 [pii] 14. Sharma RA, Mclelland HR, Hill KA, et al. Ph